Good outcomes found for both surgical dislocation and arthroscopy to treat FAI
However, arthroscopy showed a greater improvement in Level II matched-pair controlled study.
Click Here to Manage Email Alerts
Although researchers of a recently published single-surgeon prospective study that compared surgical dislocation of the hip to arthroscopy for the treatment of femoroacetabular impingement found improved patient-reported outcomes with both options, they discovered greater benefits with arthroscopy.
“Favorable results were shown with both approaches,” Timothy J. Jackson, MD, of Pasadena, Calif., said during his presentation at a recent meeting.
“There were significant improvements in outcome measures and high patient satisfaction ratings in both; however, arthroscopic treatment for femoroacetabular impingement showed higher Harris Hip and Non-Arthritic Hip Scores,” said Benjamin Domb, MD, of Hinsdale Orthopedics in Chicago, who performed the surgeries in this study.
Comparison of techniques
The study, performed at the American Hip Institute in Chicago, examined adult patients treated for femoroacetabular impingement between January 2008 and August 2011. They excluded patients with arthritis, dysplasia, Legg-Calves-Perthes disease or with a history of previous hip surgery. Patients were matched for age, gender and workers’ compensation status and elected to undergo either surgical dislocation or hip arthroscopy. There were 10 patients in the surgical dislocation group and 20 patients in the arthroscopy group. The mean patient follow-up was 24.8 months for the surgical dislocation group and 25.5 months for the arthroscopy group.
The surgical dislocation group underwent trochanteric flip osteotomy, allowing preservation of the muscular attachments during this joint-preserving open approach. Both open and arthroscopy groups underwent acetabuloplasty, femoroplasty, and labral repair. Both groups wore a hip brace for 2 weeks postoperatively. The surgical dislocation group was restricted in weight-bearing postoperatively to encourage trochanteric healing, according to Jackson.
Preoperative modified Harris Hip Scores, Non-Arthritic Hip Scores (NAHS) and Hip Outcome Score (HOS) subscales for sport (HOS-SSS) and activity of activities of daily living (HOS-ADL) were similar between the groups.
Outcomes
Both groups had favorable results, with significant improvements in outcome scores postoperatively at 3 months, 1 year and at the most recent follow-up, but the arthroscopy group had better outcomes for the absolute NAHS value and change in HOS-SSS. The NAHS was 88.1 points for the arthroscopy group compared to 75.3 points in the surgical dislocation group at 3 months, and 94.2 points for the arthroscopy group and 85.7 points for the surgical dislocation group at final follow-up. The change in HOS-SSS was 42.8 points for the arthroscopic group vs. 23.5 points for the surgical dislocation group at final follow-up. On a 10-point scale, the patient satisfaction for the arthroscopy group was 9.2 and 8.1 for the surgical dislocation group.
The alpha angle decreased in both groups. The angle went from 57° preoperatively to 40° postoperatively in the arthroscopy group and the measure dropped from 58° preoperatively to 40° postoperatively in the dislocation group.
“We sought to minimize selection bias by using a matched-pair study design with stringent matching criteria,” Jackson said. “We used the same intra-articular techniques, clinical protocols and rehabilitation (except for the weight-bearing in the surgical dislocation group). The approach became the primary variable.” – by Renee Blisard Buddle
Reference:
Jackson T. Paper #47. Presented at: American Orthopaedic Society for Sports Medicine Annual Meeting; July 11-14, 2013; Chicago.
For more information:
Benjamin G. Domb, MD, can be reached at Hindsdale Orthopaedics, and the American Hip Institute in Chicago, 1010 Executive Ct., Suite 250, Westmont, IL 60521; email: drdomb@americanhipinstitute.org.
Disclosure: Domb is a consultant for Arthrex Inc, Mako Surgical Corp., Pacira; has stock in Stryker and Mako Surgical Corp.; receives royalties from Orthomerica and DJO Global. Jackson has no relevant financial disclosures.